{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:24:42Z","timestamp":1793053482058,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.euo.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T18:18:02Z","timestamp":1649441882000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA"],"prefix":"10.1016","volume":"6","author":[{"given":"Douglas G.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheema S.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Piechocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Silcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Sale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice P.","family":"Zeegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.K.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2022.03.005_b0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1464-410X.2002.02776.x","article-title":"Delay and survival in bladder cancer","volume":"89","author":"Wallace","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.03.005_b0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1464-410X.2006.05976.x","article-title":"A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic","volume":"97","author":"Edwards","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.03.005_b0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.eururo.2018.03.008","article-title":"Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients","volume":"74","author":"Tan","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/bju.15483","article-title":"The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer \u2013 a multicentre observational study","volume":"128","author":"Khadhouri","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.03.005_b0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.euo.2022.03.005_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14040","article-title":"Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer","volume":"14","author":"Mowatt","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.euo.2022.03.005_b0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0045","doi-asserted-by":"crossref","first-page":"E680","DOI":"10.1111\/j.1464-410X.2012.11500.x","article-title":"Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis","volume":"110","author":"Zheng","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.03.005_b0050","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1464-410X.2007.07317.x","article-title":"Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder","volume":"101","author":"Bryan","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.03.005_b0055","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.eururo.2019.01.031","article-title":"Consensus in bladder cancer research priorities between patients and healthcare professionals using a four-stage modified Delphi method","volume":"76","author":"Bessa","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0060","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.euo.2022.03.005_b0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/BLC-180179","article-title":"Urinary biomarkers in the evaluation of primary hematuria: a systematic review and meta-analysis","volume":"4","author":"Sathianathen","year":"2018","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.euo.2022.03.005_b0075","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","article-title":"Diagnostic accuracy of novel urinary biomarker tests in non\u2013muscle-invasive bladder cancer: a systematic review and network meta-analysis","volume":"4","author":"Laukhtina","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2022.03.005_b0080","doi-asserted-by":"crossref","first-page":"9530","DOI":"10.1073\/pnas.1105422108","article-title":"Detection and quantification of rare mutations with massively parallel sequencing","volume":"108","author":"Kinde","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euo.2022.03.005_b0085","doi-asserted-by":"crossref","first-page":"e0149756","DOI":"10.1371\/journal.pone.0149756","article-title":"Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer","volume":"11","author":"Ward","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2022.03.005_b0090","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/s41587-021-00857-z","article-title":"Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology","volume":"39","author":"Deveson","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.euo.2022.03.005_b0095","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bju.14808","article-title":"Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification","volume":"124","author":"Ward","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.03.005_b0100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1464-410X.2009.08849.x","article-title":"The West Midlands Bladder Cancer Prognosis Programme: rationale and design","volume":"105","author":"Zeegers","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.03.005_b0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2021.02.021","article-title":"Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath study","volume":"80","author":"Bryan","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0110","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1158\/0008-5472.CAN-20-0977","article-title":"Genomic predictors of good outcome, recurrence or progression in high grade T1 non-muscle invasive bladder cancer","volume":"80","author":"Bellmunt","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2022.03.005_b0115","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ccell.2021.05.008","article-title":"Molecular classification and diagnostics of upper urinary tract urothelial carcinoma","volume":"39","author":"Fujii","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euo.2022.03.005_b0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1158\/1078-0432.CCR-18-1001","article-title":"ERCC2 helicase domain mutations confer nucleotide excision repair deficiency and drive cisplatin sensitivity in muscle-invasive bladder cancer","volume":"25","author":"Li","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2022.03.005_b0130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","article-title":"Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome","volume":"65","author":"Allory","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0135","doi-asserted-by":"crossref","first-page":"e32143","DOI":"10.7554\/eLife.32143","article-title":"Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy","volume":"7","author":"Springer","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.euo.2022.03.005_b0140","doi-asserted-by":"crossref","first-page":"102643","DOI":"10.1016\/j.ebiom.2020.102643","article-title":"Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: evidence from the Golestan Cohort Study","volume":"53","author":"Hosen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.euo.2022.03.005_b0145","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41588-021-00930-y","article-title":"Increased somatic mutation burdens in normal human cells due to defective DNA polymerases","volume":"53","author":"Robinson","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.euo.2022.03.005_b0150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/bjc.2017.210","article-title":"Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine","volume":"117","author":"Descotes","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2022.03.005_b0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bju.14459","article-title":"Does urinary cytology have a role in haematuria investigations?","volume":"123","author":"Tan","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.03.005_b0160","first-page":"384","article-title":"Performance characteristics of urinary cytology in patients presenting with gross and microscopic hematuria","volume":"9","author":"Pan","year":"2021","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13148-016-0303-5","article-title":"UroMark\u2014a urinary biomarker assay for the detection of bladder cancer","volume":"9","author":"Feber","year":"2017","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.euo.2022.03.005_b0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.juro.2016.09.118","article-title":"Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy","volume":"197","author":"van Kessel","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2022.03.005_b0175","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ejhg.2015.281","article-title":"Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA","volume":"24","author":"Tognieri","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.euo.2022.03.005_b0180","first-page":"405","article-title":"Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment","volume":"18","author":"Szarvas","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.euo.2022.03.005_b0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40169-020-0257-2","article-title":"Detection of bladder cancer using urinary cell-free DNA and cellular DNA","volume":"9","author":"Ou","year":"2020","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.euo.2022.03.005_b0190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","article-title":"Detection and surveillance of bladder cancer using urine tumor DNA","volume":"9","author":"Dudley","year":"2019","journal-title":"Cancer Discov"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931122000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931122000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:48:57Z","timestamp":1762876137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931122000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2588931122000360"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2022.03.005","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}